Fraunhofer in effort to develop robotic plant-based vax facility

The Fraunhofer Center for Molecular Biotechnology and its Center for Manufacturing Innovation have teamed with iBio Inc to develop an automated, scalable factory of sorts that uses plants for weeks-long vaccine production. Robotically tended machines plant seeds, nurture growing plants, introduce a viral vector to stimulate plant production of a target protein, and then harvest the biomass. Announcement

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.